Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine for Bipolar Depression
NCT01051440Phase 4Terminated
- Sponsor
- St. Elizabeth's Medical Center
- Start
- Feb 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Lisdexamfetamine with Placebo (2 arms). Primary endpoint: Montgomery Asberg Depression Rating Scale at 8 weeks. Started Feb 2010; status: terminated.
02
Drugs
lisdexamfetamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01051440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051440.